June 2025 On June 6, 2025, the European Medicines Agencys (EMA) safety committee concluded that Novo Nordisks semaglutide-containing drugsincluding the popular weight-loss drug Wegovy and diabetes treatments Ozempic and Rybelsusmay cause rare but serious cases of non-arteritic anterior ischemic optic neuropathy (NAION), a sudden and painless vision loss in one eye due to optic nerve damage
We look forward to continuing at Dose Level 3 and determining the dose appropriate for Phase 2. Read the full ASX Announcement here: #CHM #CDH17 #CellTherapy #CART #ASCO #Oncology #Biotech #ASCO26 American Society of Clinical Oncology (ASCO) To view or add a comment, sign in Important #LSBCMember news
It is common for vitamin B12 deficiency to coexist with other medical conditions, as troubles often come in bundles
Understanding Health at Every Size (HAES) in Womens Healthcare I am a HAES (Health At Every Size) aligned practitioner - you can learn more about HAES and what that means here
Our team focuses on understanding your goals, lifestyle, and health history to create a plan that supports long-term results